Dr. Wu Skincare Co., Ltd. Reports Earnings Results for the Second Quarter and Six Months Ended June 30, 2022
August 11, 2022
Share
Dr. Wu Skincare Co., Ltd. reported earnings results for the second quarter and six months ended June 30, 2022. For the second quarter, the company reported sales was TWD 165.8 million compared to TWD 235.26 million a year ago. Net income was TWD 52.54 million compared to TWD 24.52 million a year ago. Basic earnings per share from continuing operations was TWD 1.17 compared to TWD 0.54 a year ago. Diluted earnings per share from continuing operations was TWD 1.17 compared to TWD 0.54 a year ago.
For the six months, sales was TWD 423.22 million compared to TWD 472.82 million a year ago. Net income was TWD 163.45 million compared to TWD 109.14 million a year ago. Basic earnings per share from continuing operations was TWD 3.63 compared to TWD 2.42 a year ago. Diluted earnings per share from continuing operations was TWD 3.63 compared to TWD 2.42 a year ago.
DR.Wu Skincare Co Ltd is a Taiwan-based company mainly engaged in the research and development and sales of cosmetics and skin care products. The main products include hyaluronic acid moisturizing series, mandelic acid skin rejuvenating series, super anti-aging repair series, squalane plant extract repair series, translucent whitening series, laboratory essence series, super retinol rejuvenating series, capsule mask series, all-round sunscreen series, mineral flawless foundation series, beauty health food series, reâdermx, and others. The Company mainly distributes products in Taiwan.